Imricor
Manufacturing · Minnesota, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
400 Gateway Blvd, Burnsville, Minnesota,...Phone Number
(952) 818-8400Website
www.imricor.comRevenue
<$5 MillionStock Symbol
IMRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Imricor
Imricor is a medical technology company focused on developing and commercializing innovative MRI-compatible devices that enable physicians to perform cardiac catheter ablation procedures under real-time magnetic resonance imaging guidance, offering advanced solutions such as specialized catheters, mapping systems, and electrophysiology equipment designed to improve the precision, safety, and effectiveness of treating heart rhythm disorders while reducing reliance on traditional imaging methods, and supporting healthcare providers worldwide with integrated technologies that enhance clinical outcomes and advance the field of interventional cardiac care.Explore more
Imricor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imricor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Imricor
Funding: Get notified immidiatlly once Imricor has new funding data
Check out if Imricor is spiking on competitors!
Earning: See what the market has to say on Imricor recently announced quarterly report
Click to see if Imricor had a recent Job posting/layoffs
Product Launch: Get notified when Imricor launches new products
Check if Imricor has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Imricor, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Imricor as Masked Content
Find 3 more new buyers
Compare Similar Companies to Imricor
Compare insights from companies similar to Imricor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Imricor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Imricor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imricor.
Imricor financials insights
Gather financial insights about Imricor, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$1.6M
2026
Stock/Share Issuance
$43.1M
Imricor Tech Stack
A closer look at the technologies used by Imricor
Most Recent Scoops
Funding
Funding
Person-Based
Product Launch
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a mid-level source in advertising & promotion, is in the midst of initiatives related to video advertising. The organization is currently evaluating various vendors. Imricor will be increasing funding to support these efforts. These efforts are focused on simplifying complex stories.
Digital Marketing, Advertising, Spending/Investment, Financial Planning, Funding, Video, Finance
Project
Advertising, Business Intelligence, Analytics & Insights, Data Science, Desktop
Imricor News & Media
Imricor Commences VISABL-VT Trial
MINNEAPOLIS--(BUSINESS WIRE)-- #Cardiotwitter--Imricor announces that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI.Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
MINNEAPOLIS--(BUSINESS WIRE)-- #CardioTwitter--Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr). Dr. Laurent Fiorina, the operating Electrophysiologist at ICPS and the site’s PrDespite Imricor Medical Systems' Pullback, Insiders Still Gained US$131k
Insiders who bought Imricor Medical Systems, Inc. ( ASX:IMR ) in the last 12 months may probably not pay attention to...Imricor Medical Systems First Half 2023 Earnings: US$0.061 loss per share (vs US$0.068 loss in 1H 2022)
Imricor Medical Systems ( ASX:IMR ) First Half 2023 Results Key Financial Results Net loss: US$9.22m (loss narrowed by...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imricor
Sign Up For FreeTo access detailed company insights
Imricor is a medical technology company focused on developing and commercializing innovative MRI-compatible devices that enable physicians to perform cardiac catheter ablation procedures under real-time magnetic resonance imaging guidance, offering advanced solutions such as specialized catheters, mapping systems, and electrophysiology equipment de... Read More
